Every year, my colleagues and I put together a list of what we think are the top 10 breakthrough technologies of that year.

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly ...

HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...

HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...

A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...

A South African Medical Research Council (SAMRC) study has revealed that HIV remains one of the leading causes of death in ...

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

March is a significant month for women's health, observing International Women's Day and National Women's HIV/AIDS Awareness ...

Researchers from the HIV Prevention Trials Network (HPTN) have presented results from the HPTN 094 ("INTEGRA") study at the ...

New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and ...